购物车
- 全部删除
- 您的购物车当前为空
LMP7/LMP2-IN-1(Compound 19)作为口服有效的LMP7和LMP2免疫蛋白酶体亚基抑制剂,IC50值分别为257 nM和10 nM.本化合物能有效降低抗体生成,并减少NP-OVA免疫小鼠脾脏中生发中心B细胞和血浆细胞的数量,适用于自身免疫性疾病的相关研究.
LMP7/LMP2-IN-1(Compound 19)作为口服有效的LMP7和LMP2免疫蛋白酶体亚基抑制剂,IC50值分别为257 nM和10 nM.本化合物能有效降低抗体生成,并减少NP-OVA免疫小鼠脾脏中生发中心B细胞和血浆细胞的数量,适用于自身免疫性疾病的相关研究.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | LMP7/LMP2-IN-1 (Compound 19) is an orally effective inhibitor targeting the immunoproteasome subunits LMP7 and LMP2, with respective IC50 values of 257 and 10 nM. This compound reduces the production of antibodies and downregulates the B cells in the germinal centers of the spleen and plasma cells in NP-OVA immunized mice. It has potential applications in the study of autoimmune diseases. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容